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The carnitine transporter was solubilized from rat renal apical plasma membrane (brush-border membrane) with C12E8 and
reconstituted into liposomes by removing the detergent from mixed micelles by hydrophobic chromatography on Amberlite XAD-4. The
reconstitution was optimised with respect to the protein concentration, the detergent/phospholipid ratio and the number of passages
through a single Amberlite column. The reconstituted carnitine transporter catalysed a first-order antiport reaction (carnitine/carnitine or
carnitine/substrate) stimulated by external, not internal, Na+, with a positive cooperativity. Na+ was co-transported with carnitine. Optimal
activity was found between pH 5.5 and pH 6.0. The sulfhydryl reagents MTSES, MTSET and mercurials strongly inhibited the transport.
Substrate analogues inhibited the transport; the most effective were acylcarnitines and betaine, followed by dimethylglicine,
tetraethylammonium and arginine. Besides carnitine, only acylcarnitines and betaine were efficiently translocated. The Km for carnitine
on the external and internal side of the transporter was 0.08 and 1.2 mM, respectively. The transporter is asymmetrical and it is
unidirectionally inserted into the proteoliposomal membrane with an orientation corresponding to that of the native membrane. The
reconstituted carnitine transporter corresponds, very probably, to the OCTN2 protein.
D 2004 Elsevier B.V. All rights reserved.Keywords: Plasma membrane; Transport; Liposome; Reconstitution; Carnitine; OCTN21. Introduction
Carnitine transport across the plasma membrane of
mammalian cells is an essential requisite for the mainte-
nance of the carnitine homeostasis that results from the
balance among endogenous synthesis, absorption from
dietary sources, elimination and reabsorption by the
kidney. The homeostasis allows carnitine to fulfil impor-
tant metabolic functions, the most known of which are:
(i) h-oxidation of fatty acids in mitochondria and perox-
isomes, (ii) elimination of selective acyl residues, (iii)
modulation of CoASH/acylCoA ratios [1–3]. Carnitine
transport systems for intestinal absorption and renal
reabsorption are widely distributed in mammalian tissues.0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.12.001
Abbreviations: p-OHMB, p-hydroxymercuribenzoate; p-CMBS, p-
chloromercuribenzenesulfonate; MTSES, sodium(2-sulfonatoethyl)metha-
nethiosulfonate; MTSET, [2-(trimethylammonium)ethyl]methanethiosulfo-
nate; CxEy, alkyl(x)-poly( y)oxyethylene ether
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heart cells or in brush-border membrane vesicles ([4,5];
see Refs. [1,6] for reviews), three members of the OCTN
sub-family, which encode carnitine transport proteins,
have been recently cloned ([7–9]; see Ref. [10] for a
review).
The OCTN’s tissue distribution has been investigated.
RT-PCR, Western blot analysis and in situ hybridization
studies, in mouse or rat, showed that OCTN1 and -2 are
expressed in kidney, whereas OCTN3 is strongly
expressed in testis and not in kidney [9–11]. Further-
more, by immunohistochemical method, OCTN2 has been
localized on the apical (not on the basolateral) membrane
of the renal epithelial cells [12,13]. Several mutations of
the OCTN2 gene are known; they cause primary carnitine
deficiency ([14,15]; see Refs. [2,10] for reviews).
Functional studies of plasma membrane carnitine trans-
porters have been performed till now in brush-border
vesicles or in (over)expressing cell systems [8,9,11–
13,16–19]. By these experimental approaches, some
properties of the OCTN2 protein have been clarified:
for example, it catalyses a sodium-dependent carnitine
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and tetraethylammonium inhibit the carnitine transport.
However, there is still contradictory information about the
transport of carnitine and its derivatives across the cell
plasma membrane [2,3,10]. So far, the procedure of
reconstitution into liposomes has never been applied to
these transporters; indeed, it has been successfully used
for exhaustive functional characterization of several mi-
tochondrial transport systems, both extracted from native
membranes [20,21] or deriving from bacterial overexpres-
sion [22–26], including the mitochondrial carnitine/acyl-
carnitine carrier [27,28] that is essential for the h-
oxidation of fatty acids. The reconstitution into liposomes
has also been used for the functional study of some
plasma membrane transport systems, other than carnitine
transporters [29–36]. With the aim to provide an addi-
tional tool for the study of functional properties of the
plasma membrane carnitine transporter(s), we have point-
ed out a procedure for efficient and reproducible recon-
stitution into liposomes of a carnitine transport system,
extracted by detergent solubilization from the apical
membrane of tubular renal cells (brush-border mem-
branes). Novel functional aspects of this transporter, most
probably corresponding to OCTN2, are revealed; further-
more, the procedure described represents a tool for
functional studies of carnitine transporters not only from
native membrane, but also from overexpressing cells.2. Materials and methods
2.1. Materials
Amberlite XAD-4, egg yolk phospholipids (3-sn-phos-
phatidylcoline from egg yolk) and C12E8 were purchased
from Fluka; L-[3H] carnitine from Amersham; cardiolipin,
Sephadex G-75, Triton X-100, Triton X-114, L-carnitine
and its acyl derivatives from Sigma. All other reagents
were of analytical grade.
2.2. Solubilization of the carnitine transporter
Brush border membranes were prepared from rat
kidney as previously described [37]. The enrichment of
apical membrane was assessed by the alkaline phospha-
tase specific activity; in the preparation used for the
experiments here described, an increase of 15–18-fold
of the specific activity of the alkaline phosphatase, with
respect to the homogenate, was measured. Contamination
of the brush border membrane by mitochondria was
excluded due to the absence of glutamate dehydrogenase
activity. Membrane preparations were divided into ali-
quots of 50 Al and stored at 80 jC. The carnitine
transporter was solubilized by treating the membrane
preparation with 2% C12E8 in a buffer containing 10
mM HEPES/Tris pH 7.0 and centrifuged at 13000g for15 min at 4 jC. The supernatant (extract) was used for
the reconstitution.
2.3. Reconstitution of the carnitine transporter into
liposomes
The carnitine transporter was reconstituted by remov-
ing the detergent with a hydrophobic chromatography
column [20,21]. In this procedure the mixed micelles
containing detergent, protein and phospholipids were
repeatedly passed through the same Amberlite XAD-4
column. The composition of the initial mixture used for
reconstitution was: 25 Al of the solubilized protein (15–
25 Ag protein in 2% C12E8), 85 Al of 10% C12E8, 100
Al of 10% egg yolk phospholipids in the form of
sonicated liposomes prepared as described in Ref. [20],
10 mM L-carnitine, 20 mM HEPES/Tris (pH 6.0) in a
final volume of 700 Al. After vortexing, this mixture was
passed 15 times through the same Amberlite column
(0.53 cm) preequilibrated with a buffer containing 20
mM HEPES/Tris (pH 6.0) and 10 mM L-carnitine. All
the operations were performed at 4 jC, except the
passages through Amberlite, which were carried out at
room temperature.
2.4. Transport measurements
To remove the external substrate, 550 Al of proteoli-
posomes was passed through a Sephadex G-75 column
(0.715 cm) preequilibrated with 10 mM HEPES/Tris
(pH 6.0). Transport was started by adding [3H] carnitine
at the indicated concentrations to the proteoliposomes and
stopped by adding 50 AM mersalyl at the desired time
interval. In control samples the inhibitor was added at
time zero according to the inhibitor stop method [38].
The assay temperature was 25 jC. Finally, each sample
of proteoliposomes (100 Al) was passed through a
Sephadex G-75 column (0.68 cm) in order to separate
the external from the internal radioactivity. Liposomes
were eluted with 1 ml 50 mM NaCl and collected in 4
ml of scintillation mixture, vortexed and counted. The
experimental values were corrected by subtracting the
respective control. The mersalyl-insensitive radioactivity
associated to the control samples was always less than
15% with respect to the mersalyl-sensitive carnitine
transport. For kinetic determinations, the initial rate of
transport was measured by stopping the reaction after 10
and 20 min, i.e., within the initial linear range of
[3H]carnitine uptake into the proteoliposomes.
2.5. Other methods
The protein concentration was determined by the mod-
ified Lowry procedure [39]. The internal volume of the
proteoliposomes was measured as previously described
[20,40].
Fig. 2. Time course of [3H]carnitine uptake by reconstituted proteolipo-
somes. 10 AM [3H]carnitine was added at time zero to proteoliposomes
containing 10 mM internal carnitine (o,.) or without internal substrate (5,
E), in the presence (., E) or in the absence (o, 5) of 50 mM external
NaCl; the transport reaction was stopped at the indicated times, as described
in Materials and methods. Similar results were obtained in three different
experiments.
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3.1. Optimal conditions for reconstitution
To solubilize the carnitine transporter in active form,
several non-ionic detergents were tested: Triton X-100,
Triton X-114, C12E8, C8E4, lauryl (dimethyl) amine N-
oxide, n-octyl polydisperse oligo-oxyethylene. The most
suitable for the solubilization of the protein in active form
was C12E8 at a concentration of 2%. Triton X-100 led to the
extraction of active protein with 70% activity with respect to
C12E8; Triton X-114 led to the extraction of apparently
active protein: however, in this case, a higher level of
mersalyl-insensitive radioactivity associated to the control
samples (see Materials and methods) was measured, prob-
ably due to a higher permeability of the proteoliposomes
formed in the presence of this detergent; the other detergents
were nearly ineffective in the solubilization of active carni-
tine transporter (experiments not shown).
The reconstitution procedure has been optimised for the
carnitine transporter by adjusting the parameters that influ-
ence the efficiency of transport protein incorporation into
the liposomes [20,21]. In these experiments, both the
transport at 15 min and the total transport after 120 min
were measured. The first parameter, which is proportional to
the transport rate (see Materials and methods and Fig. 2),
gives information on the specific activity of the transporter,
whereas the second is correlated to the number (and/or size)
of the liposomes loaded with active carrier. Transport was,
in any case, measured as [3H] carnitine/carnitine (10 AM/10
mM) antiport. The total intraliposomal volume has also been
measured to verify the efficiency of reconstitution.
In Fig. 1 the influence of the protein concentration on the
reconstituted transporter is shown. Both the transport rate andFig. 1. Dependence of the efficiency of reconstitution of the carnitine
transporter on protein concentration. The reconstitution was performed as
described in Materials and methods except that increasing concentrations of
protein were used. Transport was measured as 10 AM [3H]carnitine uptake
into proteoliposomes containing 10 mM carnitine, in the presence of 50
mM external NaCl, in 15 min (o) or in 120 min (.); (D) internal volume
of the proteoliposomes. Similar results were obtained in three different
experiments.the total transport increased with the protein concentration up
to about 25 Ag/ml. Above this value, a plateau and/or a little
reduction of both the transport rate and the total transport was
observed. The intraliposomal volume decreased by increas-
ing the protein concentration, indicating that higher concen-
trations of protein cause the formation of less or smaller
liposomes; thus, for the experiments, we have chosen a
protein concentration of about 20 Ag/ml, which represents a
good compromise between optimal activity and internal
volume.
Other critical parameters for the method of reconstitu-
tion used in this work are the detergent/lipid ratio and the
number of passages of the reconstitution mixture through
the Amberlite column. Broad optimal conditions were
found at detergent/lipid ratio of 0.9 and 15 column
passages (experiments not shown).
Cardiolipin has been reported to be essential for the
activity of the mitochondrial carnitine carrier [28,41,42].
This phospholipid did not exert any influence on the activity
of the reconstituted carnitine transporter from plasma mem-
brane upon addition during the solubilization or the recon-
stitution at concentrations ranging from 20 to 200 Ag/ml (not
shown).
3.2. Functional characterization
The dependence of the transport activity of the carnitine
transporter has been studied as function of the time of
incubation of the proteoliposomes with 10 AM external
labelled carnitine under different experimental conditions:
in the presence or in the absence of intraliposomal carnitine
and in the presence or in the absence of external NaCl. The
results are summarized in Fig. 2. The accumulation of [3H]
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tine increased as a function of time; on the contrary, virtually
no accumulation of radioactivity was observed in the vesicles
without internal substrate, indicating that the transport pro-
cess occurs by an antiport mode (carnitine/carnitine homo-
exchange). The [3H] carnitine/carnitine antiport was strongly
stimulated by the presence of external NaCl; in this case the
radioisotopic equilibrium was reached after about 160 min;
the experimental data describing the transport of carnitine in
the absence and in the presence of external NaCl, both fitted a
first order rate equation; the first order rate constant, k,
resulted to be 0.005 and 0.013 min1, the transport rateFig. 3. Dependence of carnitine transport on the concentration of NaCl in
the extraliposomal (A) or intraliposomal (B) compartment. Transport rate
was measured as 10 AM [3H]carnitine uptake into proteoliposomes
containing 10 mM carnitine, as described in Materials and methods. In
(A), NaCl (.), LiCl (E) or KCl (n) was added at the indicated
concentrations outside the proteoliposomes; in (B), NaCl was included at
the indicated concentrations inside the proteoliposomes in the reconstitution
mixture and the transport rate was measured in the absence (o) or in the
presence (.) of external 50 mM NaCl. Similar results were obtained in four
different experiments.
Fig. 4. Effect of pH on the reconstituted carnitine transporter. All the
experimental procedures from the reconstitution to the transport measure-
ment (see Materials and methods) were performed in 20 mM HEPES/Tris
buffer at the indicated pH. Transport rate was measured as 10 AM [3H]
carnitine uptake into proteoliposomes containing 10 mM carnitine, in the
presence of 50 mM external NaCl. The results are meansFS.D. of triplicate
samples of one experiment. Similar results were obtained in three different
experiments.(calculated as the product of k and the transport at equilibri-
um) was 8.5 or 36.4 pmol/min/mg protein in the absence or in
the presence of NaCl, respectively.
To gain further insight on the stimulation of the
carnitine antiport, the dependence of the transport on the
concentration of externally added cations, as Cl salts, was
studied. The data of Fig. 3A show that the transport rate of
carnitine antiport, starting from about 8 pmol/min/mg
protein at 0 mM salt, was strongly stimulated by external
NaCl, reaching a value of about 60 pmol/min/mg protein
at 100 mM NaCl. The stimulation followed a sigmoidal
dependence on the NaCl concentration. The data were
interpolated by the Hill allosteric kinetic equation; half
maximal effect was given by 48 mM NaCl (52F8.5 from
4 experiments) and the cooperativity index was 2.1
(1.8F0.4 from 4 experiments). LiCl exerted a stimulatory
effect much lower than that of NaCl; KCl and (not shown)
NH4Cl, tetraethylammonium (chloride) and choline (chlo-
ride), had a negligible effect. In other experiments it was
found that the stimulation of carnitine transport, by 25 mM
Na2SO4 or 50 mM NaAcetate, was coincident to that of 50
mM NaCl (not shown) demonstrating, together with the
data of Fig. 3A, that the stimulatory effect is due to the
Na+ cation. In a different experiment we studied the
dependence of the transport on internal NaCl concentra-
tion, both in the presence and in the absence of external
Na+. As shown in Fig. 3B, Na+ did not stimulate the
transport when present inside the proteoliposomes, nor in
the presence neither in the absence of external Na+. If any,
a light inhibition effect was observed at higher internal
Na+ concentrations. Similar results were obtained with
Na2SO4 or NaAcetate (not shown).
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carnitine, external [3H] carnitine, together with [22Na]Cl, was
incubated with the proteoliposomes. At Na+ concentrations
ranging from 1 to 10 mM, the time courses of carnitine and
Na+ were nearly coincident, indicating a 1:1 stoichiometry of
transport (experiment not shown).
The dependence of the carnitine antiport on the pH has
been studied (Fig. 4). Maximal transport activity was ob-
served in an acidic pH range between pH 5.5 and pH 6.0. Out
of this range, the transport activity was much lower.
The sensitivity of the carnitine antiporter to inhibitors was
studied. Inhibitors were chosen among protein-modifying
reagents or molecules structurally related with the substrate.
As reported in Table 1, the carnitine antiport was strongly
inhibited by known SH reagents; the mercurials HgCl2,
mersalyl, p-OHMB and p-CMBS and the methanthiosulfo-
nates MTSES and MTSETwere the most effective; other SHTable 1
Effect of inhibitors on the reconstituted carnitine transport
Inhibitor Concentration (mM) Inhibition (%)
HgCl2 0.05 88F7.8
Mersalyl 0.05 100
p-Hydroxymercuribenzoate 0.05 93F10
p-Chloromercuribenzensulfonate 0.05 98F13
MTSET 0.05 101F9.1
MTSES 0.05 99F12
N-Ethylmaleimide 0.05 38F3.5a
N-Ethylmaleimide 0.5 86F11
N-Phenylmaleimide 0.05 21F4.2a
N-Phenylmaleimide 0.5 74F8.6a
Bathophenanthroline 10 54F8.4a
Pyridoxal-5-phosphate 15 27F6.7a
L-Acetylcarnitine 0.1 51F7.5a
L-Acetylcarnitine 1 91F9.7
L-Acetylcarnitine 5 101F8.3
L-Propionylcarnitine 5 95F10
L-Octanoylcarnitine 5 96F7.4
L-Decanoylcarnitine 5 92F8.6
L-Palmitoylcarnitine 0.1 37F12a
L-Palmitoylcarnitine 1 82F12
Betaine 1 92F9.0
Dimethylglycine 1 48F6.3a
Glycine 1 22F4.1a
Tetraethylammonium 1 43F3.5a
Choline 1 27F3.3a
Ammonium chloride 1 23F8.8a
Arginine 1 42F5.4a
Creatine 1 17F4.0a
Trimethyl-lysine 1 14F3.5a
Transport was measured as 10 AM [3H] carnitine uptake into proteolipo-
somes, reconstituted as described in Materials and methods, containing 10
mM internal carnitine, in the presence of 50 mM external NaCl, in 40 min.
The inhibitors were added 1 min before the labelled substrate at the
concentrations indicated. Percent of transport inhibition was calculated for
each experiment with respect to the control sample (referred as 100%), i.e.
proteoliposomes treated with 0.05 mM mersalyl. The results are
meansFS.D. of the percentages for three experiments. The average
transport activity of the control samples of the three experiments analysed
was 1200F422 pmol/40 min/mg protein.
a Significantly different from the control (100%) as estimated by
Student’s t test ( P<0.05).
Fig. 5. Dependence on substrate concentration of the rate of carnitine
antiport. [3H]carnitine at the indicated concentration was added to
proteoliposomes containing 10 mM internal carnitine in the absence (.)
or in the presence of 0.1 mM acetylcarnitine (o), 0.3 mM betaine (5), (A);
or 0.5 mM [3H]carnitine was added to proteoliposomes containing internal
carnitine at the indicated concentrations (B); the transport rate was
measured, as described in Materials and methods, in the presence of 50 mM
external NaCl. Data were plotted according to Eadie-Hofstee. Similar
results were obtained in five different experiments.reagents like N-ethylmaleimide and N-phenylmaleimide had
a lower inhibitory effect, even though by increasing their
concentration up to 0.5 mM an inhibition of 86% and 74%
was observed with N-ethylmaleimide and N-phenylmalei-
mide, respectively. Pyridoxal-5-phosphate, which reacts with
Lys amino groups, and bathophenanthroline, a metal chelat-
ing reagent, exerted a low inhibitory effect even at very high
concentrations. Among the substrate analogues, carnitine
acyl esters were tested; acetylcarnitine led to about 50%
inhibition at 0.1 mM, i.e. at a concentration close to the Km
of the transporter for carnitine (see below); 5 mM acetylcar-
nitine led to complete inhibition; 5 mM propionylcarnitine,
octanoylcarnitine and decanoylcarnitine led to a nearly com-
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since it has a detergent effect at higher concentrations [28]; at
the concentration tested, it was little less effective than
acetylcarnitine, i.e., the affinity of the carrier towards long-
chain acylcarnitines was slightly lower than that for carnitine
and acetylcarnitine. Betaine also was a very effective inhib-
itor; the removal ofN-methyl groups led to a gradual decrease
of inhibition in dimethylglycine and glycine. A reduction of
inhibition was also observed in the absence of the carboxyl
group; tetraethylammonium had a middle effect, choline and
ammonium chloride were poor inhibitors. The amino acid
arginine had an effect similar to tetraethylammonium; crea-
tine and trimethyl-lysine had a very poor, if any, effect. No
significant protection of mersalyl or N-ethylmaleimide inhi-
bition by carnitine was found, indicating that the SH residues
should not be located in the active site. By studying the
carnitine transport kinetics in the absence and presence of
acetylcarnitine or betaine (see Fig. 5A), competitive inhibi-
tion was found, indicating that these inhibitors interact with
the active site.
To establish which of the inhibitors could also be trans-
ported, the experiment of Table 2 has been performed. In this
experiment, the ability of the internal substrates to be ex-
changed with external labelled carnitine has been tested. To
compare the effect of palmitoylcarnitine (that cannot be usedTable 2
Dependence on internal substrate of carnitine transport in reconstituted
liposomes
Internal
substrate
Concentration
(mM)
Carnitine
transport
(% of the control)
None <5
L-Carnitine 1 or 10 100
L-Acetylcarnitine 1 98F8.7
L-Acetylcarnitine 10 102F9.9
L-Propionylcarnitine 10 96F11
L-Palmitoylcarnitine 1 93F13
Dimethylglycine 10 <5
Glycine 10 <5
Betaine 10 81F7.5a
Choline 10 <5
Creatine 10 <5
Arginine 10 <5
Tetraethylammonium 10 16F4.2a
Ammonium chloride 10 <5
Trimethyl-lysine 10 <5
Internal substrates were included in the reconstitution mixture (see
Materials and methods). After the removal of external substrate on
Sephadex G-75, transport was measured as 10 AM [3H] carnitine uptake
into the proteoliposomes in the presence of 50 mM external NaCl, in 40
min. Percent of carnitine transport was calculated for each experiment with
respect to its control sample (referred as 100%), i.e. proteoliposomes
containing 1 mM or 10 mM internal carnitine. The results are meansFS.D.
of the percentages for three experiments. The average transport activity of
the control samples of the three experiments analysed was 259F117 pmol/
40 min/mg protein at 1 mM internal carnitine or 1390F568 pmol/40 min/
mg protein at 10 mM internal carnitine.
a Significantly different from the control (100%) as estimated by
Student’s t test ( P<0.05).at concentrations higher than 1 mM) with that of the control,
two conditions of internal carnitine concentration (controls)
were used: 1 and 10 mM. As clearly demonstrated by the data
in Table 2, the carnitine acyl derivatives and betaine were
efficiently transported in antiport for external carnitine; on the
contrary, with the exception of tetraethylammonium that was
transported with a very low efficiency, all the other substrates
tested were not transported, in spite of the inhibitory effect
observed in the experiment of Table 1.
To obtain the basic kinetic data of the carnitine transporter,
the dependence of the antiport rate on both external and
internal substrate concentration was studied by changing
alternatively the carnitine concentration in one compartment
at fixed (close to saturation) carnitine concentration on the
opposite compartment. The experimental data were plotted
according to Eadie-Hofstee; in this representation the Km
value corresponds to the slope and, hence, the hypothetical
presence of more than one Km is easily detectable. As shown
by Fig. 5A and B, on both sides of the membrane, only one
slope (Km) is measured. The Km outside is much lower than
the Km inside: the mean value from five different experi-
ments was 80F11 AMor 1.2F0.25 mM on the external or the
internal side, respectively. The Vmax values from the two
experiments were similar. The mean value from 10 different
experiments was 350F162 pmol/min/mg protein. The stan-
dard deviation of the Vmax was very high when comparing
different experiments, probably due to variations in the
amount of active transport protein molecules present in each
preparation.4. Discussion
In this paper we have studied the carnitine transporter from
renal cell plasma membrane by reconstitution into liposomes.
The reconstitution system leads to some advantages, with
respect to intact cells or brush-border membrane vesicles, like
the possibility to control the experimental conditions in the
internal compartment, which allows the determination of
both the internal substrate affinity or the effect of various
molecules; the reduction of interferences due to the virtual
absence of external and internal enzymes; a longer radioac-
tivity equilibration time (especially with respect to brush-
border membrane vesicles), due to the low protein/lipid ratio
(one or few protein per liposome), which leads to a better
kinetic resolution; the possibility of modifying the lipid
composition of the membrane; the potential application on
expressed transporters. In addition, the reconstitution proce-
dure here used leads to the formation of proteoliposomes
larger than those obtained by other methods like the freeze-
thaw sonication [20,21]; this feature allows to increase the
accumulation of radioactivity inside the active vesicles, i.e.
the proteoliposomes containing active transporters inserted
into the membrane.
We have identified the reconstituted carnitine transporter
as the rat OCTN2 for the following reasons: (i) the source of
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methods) corresponds to the location of the OCTN2 [9,11–
13]; (ii) the Na+ stimulation and the specificity for carnitine,
its acyl derivatives, betaine, tetraethylammonium and choline
are nearly coincident to those reported for the rat OCTN2
expressed in cells [11] and very similar to those of OCTN2
from other sources [8,9,16,19]; (iii) the ratio between the
transport of carnitine and that of the poor substrate tetraethy-
lammonium (6.25) is closer to the ratio reported for mouse
OCTN2 than to those of mouse OCTN1 and OCTN3 [9,19].
On the other hand, different functional features are reported
for OCTN1 [10] and different features and location for
OCTN3 [9]. In addition, we can exclude that the carnitine
transporter is an unknown member of the OCTN sub-family,
since no further member, besides OCTN1-3, can be identified
up to date, by aligning the rat OCTN2 cDNA or protein with
all non-redundant data bases (http://www.ncbi.nlm.nih.gov/
BLAST/); see also [9].
By using the optimised reconstituted system, we have
provided additional functional information on the transport
system or have clarified some uncertainties previously
reported [2,3,10,43]. Interestingly, we have found that it
catalyses a peculiar mode of transport: an obligatory anti-
port of carnitine and other substrates (Fig. 4 and Tables 1
and 2), coupled to external (not internal) Na+ co-transport
with carnitine; this mechanism is in agreement with previ-
ous conclusions on the OCTN2 overexpressed in cells [19].
The reconstituted carnitine transporter has a very low
tolerance for Li+ as found for OCTN2 in cells [8,13]. For
optimal translocation efficiency, the substrates must fulfil at
least two requirements: the presence of a carboxylic group
(the absence of this functional group in the choline does not
allow transport); the presence, on the opposite end of the
molecule, of a charged three-substituted amino group
(dimethylglycine that lack only one N-methyl group inter-
acts and inhibits the transporter, but is not translocated).
Differently, the distance between the two essential groups is
not very critical: one (betaine) or three (carnitine) carbon
atoms between the carboxylic and the amino group are
accepted; the presence of an acyl group esterified with the
h-hydroxyl group of carnitine is accepted without apparent
restrictions. The substrate specificity of the carnitine plasma
membrane transporter towards acylcarnitines is quite dif-
ferent from that of the mitochondrial carnitine/acylcarnitine
carrier; the first shows highest affinity for carnitine and
short-chain acylcarnitines; on the contrary, the second has
an affinity towards long-chain acylcarnitines much higher
than that for carnitine and short-chain acylcarnitines [27].
Furthermore, the carnitine transporter efficiently catalyses
the transport of betaine, the mitochondrial carrier does not
(Indiveri, C. et al. unpublished results). The pH dependence
of the reconstituted carnitine transporter is different from
that reported for the mouse OCTN2 in cell system [9];
however, as stated by the author themselves, the pH
dependence of OCTN2 in cells was in contrast with the
acidic pH of the renal tubules; on the contrary, the pHdependence found here is in good agreement with the
physiological context.
The external Km value found in the reconstituted system is
similar, or higher than, values reported for the carnitine
transporter in brush-border vesicles ([10] and see Ref. [17]
for references), similar to a value reported for OCTN2
expressed in RBE4 cells [18] and higher than the values
reported for OCTN2 from various sources expressed in
different cell systems [8,11–13]. The first determination of
internal Km is described here: it is about one order of
magnitude higher than the external Km; thus, the transporter
is functionally asymmetrical in agreement with the sidedness
of the Na+ regulation. It has an unidirectional orientation,
since a single Km value is found on each side of the
membrane and no activation by internal Na+ can be observed.
The orientation of the reconstituted transporter should corre-
spond to that of the native membrane since, as in the cell, the
Na+ regulation site is located outside the proteoliposomes.
The functional asymmetry corresponds to the structural
asymmetry of the OCTN2 transport protein, deduced on the
basis of the hydropathy profile analysis [2,8,10]. The protein
has 12 transmembrane a-helices connected by hydrophilic
loops of very different size on the two sides of the transporter.
On the basis of the sequence analysis, the larger hydrophilic
loop should be located on the external side of the cell, due to
the presence of potential glycosylation sites [2,8]. The
inhibition of the reconstituted transporter, caused by exter-
nally added membrane impermeant [44] SH reagents
MTSES, MTSET and p-CMBS (Table 1), can only be
explained by the exposure of Cys residues towards the
extraliposomal side. Since all the four Cys in the hydrophilic
moiety of the OCTN2 protein (the remaining 2 Cys are in the
transmembrane segments) are located in the large extracel-
lular loop that carries the glycosylation sites, the extracellular
loop must also be extraliposomal.
The data described are in agreement with a physiological
role of this transporter in the reabsorption of carnitine from
the tubular lumen by exchanging it with molecules like
carnitine acyl esters or other metabolites, which must be
excreted [1–3,6]. Thus, the export of these metabolites does
not occur by passive diffusion as previously hypothesized
(see Refs. [2,3] for reviews). The transport mechanism of the
carnitine transporter, i.e., the antiport coupled with Na+ co-
transport, allows to fulfil the function by a single transporter
and to reduce the osmotic imbalance that may be generated by
the simple co-transport of carnitine plus Na+.
This paper, in our knowledge, represents the first example
of reconstitution of a carnitine transporter from plasma
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